A. Kristoffersson

发表

Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites.

Didier Rognan, Chris de Graaf, Steve Price, 2009, Journal of medicinal chemistry.

Rapidly increasing off‐label use of rituximab in multiple sclerosis in Sweden — Outlier or predecessor?

S. Berntsson, I. Boström, A. Landtblom, 2018, Acta neurologica Scandinavica.

Organic solvent exposure as a risk factor for multiple sclerosis: An updated review.

I. Boström, A. Landtblom, A. Kristoffersson, 2019, Revue neurologique.

Aniridia with PAX6 mutations and narcolepsy

M. Partinen, A. Markström, S. Berntsson, 2020, Journal of sleep research.

Inventory study of an early pandemic COVID-19 cohort in South-Eastern Sweden, focusing on neurological manifestations

M. Fredrikson, A. Landtblom, E. Iacobaeus, 2023, PloS one.

4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).

B. Nordén, J. Larsson, A. Kristoffersson, 2010, Bioorganic & medicinal chemistry letters.